Association of expression of CD44v6 with systemic anaplastic large cell lymphoma: Comparison with primary cutaneous anaplastic large cell lymphoma

American Journal of Clinical Pathology

Volumn 117, Issue 2, 2002, Pages 276-282

  Liang, Xiayuan ^a   Golitz, Loren E ^a   Smoller, Bruce R ^a   Meech, Sandra J ^a   Odom, Lorrie F ^a   Williams, Sara A ^a   Ryder, John W ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

Anaplastic large cell lymphoma; CD44; CD44v6; Immunohistochemistry

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD44V ANTIGEN; CD44V6 ANTIGEN; CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SKIN CARCINOMA;

EID: 0036329039     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/TRW0-KXWV-QWG0-9XDF     Document Type: Article

References (49)

1. Homing receptors and the control of lymphocyte migration
2. Phenotypic identification of memory cytolytic T lymphocytes in a subset of Lyt-2+ cells
3. Distinction of virgin and memory T lymphocytes: Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation
4. Differentiation of human T lymphocytes, 1: Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation
5. CD44: Structure, function, and association with the malignant process
6. CD44: A molecule involved in leukocyte adherence and T cell activation
7. CD44: The hyaluronan receptor
8. CD44: A multitude of isoforms with diverse functions
9. CD44 and its interaction with extracellular matrix
10. Are CD44 variant isoforms involved in human tumor progression?
11. The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms
12. CD44: A variety of isoforms with functions in cell adhesion and tumor metastasis
13. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
14. Prevention of tumor metastasis formation by anti-variant CD44
15. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: Characterization and comparison with normal activated B cells and epithelial malignancies
16. CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor
17. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
18. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997
19. CD30(+) anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology
20. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma
21. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
22. NPM/ALK expression
23. NPM/ALK: A distinct clinicopathologic entity
24. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleoplasmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1
25. CD30+ anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features
26. CD30/Ki-1-positive lymphoproliferative disorders of the skin: Clinicopathologic correlation and statistical analysis of 86 cases: A multicenter study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group
27. EORTC classification for primary cutaneous lymphoma: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
28. Report of the Committee on Hodgkin's Disease Staging Classification
29. Expression of lymphocyte homing receptor (CD44) as a mechanism of dissemination in non-Hodgkin's lymphoma
30. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44), LFA-1 (CD1 la/18), and ICAM-1 (CD54)
31. Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma
32. Distinct effects of two CD44 isoforms on tumor growth in vivo
33. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma
34. Activated human lymphocytes and aggressive non-Hodgkin's lymphoma express a homologue of the rat metastasis-associated variant of CD44
35. Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-sepharose
36. Purification and some properties of streptococcal protein G: A novel IgG-binding reagent
37. Analysis of adhesion molecules in Ki-1 anaplastic large-cell lymphoma
38. Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes
39. Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma
40. CD44 and cancer screening
41. Expression and modulation of CD44 variant isoforms in humans
42. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas
43. Adhesion molecules in the dissemination of non-Hodgkin's lymphomas
44. Participation in normal immune responses of a metastasis-inducing splice variant of CD44
45. Pathology of malignant lymphomas
46. Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma
47. Peripheral T-cell and NK-cell neoplasms: An integrated approach to diagnosis
48. Anaplastic large cell lymphoma: The shifting sands of diagnostic hematopathology